Minerva Neurosciences (NERV) Tops Q3 EPS by 398c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of $2.97, $3.98 better than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Waymo Explores Split With Uber - FT
• Replimune (REPL) files for 25.1M share offering by selling stockholders
• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion